GB1196596A — Preparation of a hydroxysebacic acid
Assigned to Geigy Co Ltd · Expires 1970-07-01 · 56y expired
What this patent protects
1,196,596. Preparation of 5-hydroxysebacic acid. GEIGY (U.K.) Ltd. 23 Nov., 1967 [21 Dec., 1966], No. 21513/68. Divided out of 1,196,594. Heading C2C. 5-Hydroxysebacic acid or an alkali metal salt thereof is prepared by hydrolysing 6- hydroxy-1,10 decanedioic acid-1,61 actone wit…
USPTO Abstract
1,196,596. Preparation of 5-hydroxysebacic acid. GEIGY (U.K.) Ltd. 23 Nov., 1967 [21 Dec., 1966], No. 21513/68. Divided out of 1,196,594. Heading C2C. 5-Hydroxysebacic acid or an alkali metal salt thereof is prepared by hydrolysing 6- hydroxy-1,10 decanedioic acid-1,61 actone with an aqueous medium containing an alkali metal hydroxide. The hydrolysis is preferably carried out by heating the reaction mixture for up to 3 hours under reflux conditions.
Drugs covered by this patent
- Nexletol (BEMPEDOIC ACID) · Esperion Theraps Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.